NCT02940535

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response: a Randomized Control Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Navy General Hospital, Beijing · Academic / Other
• Sex: Female
• Age: 35 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The management of the poor responder patients is very difficult. Currently, there is no any standard treatment for poor responder patients. The study is designed to test a modified GnRHa protocol for poor ovarian response, low dose GnRHa early luteal phase down regulation, compare with GnRHa ultra-short protocol. This is a randomized controlled trial.

Conditions

• Subfertility, Female
• Ovulation Disorder

Interventions

Type	Name	Description
DRUG	Diphereline (Triptorelin embonate)
DRUG	Decapeptyl (Triptorelin)
DRUG	human menopausal gonadotropin
DRUG	human chorionic gonadotropin

Timeline

• Start date: 2016-12-01
• Primary completion: 2019-12-01
• Completion: 2020-12-01
• First posted: 2016-10-21
• Last updated: 2016-10-21

Locations

1 site across 1 country: China